Optimizerx To Participate In Upcoming Investor Conferences
| Stifel 2026 Boston Cross Sector 1x1 Conference | |
| Date: | Tuesday, June 2, 2026 |
| Format: | 1x1 Meetings |
| Location: | InterContinental Boston |
| William Blair & Company's 46 th Annual Growth Stock Conference | |
| Date: | Wednesday, June 3, 2026 |
| Format: | 1x1 Meetings and Corporate Presentation |
| Location: | Loews Hotel Chicago |
| Presentation Time: | 8-8:30 am CDT |
To request a meeting or for more details about the conferences please reach out to your institutional contact.
About OptimizeRx
OptimizeRx is a leading healthcare technology company that's redefining how life science brands connect with patients and healthcare providers. Our platform combines innovative artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and DTC strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.
Our commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world's leading pharmaceutical and life sciences companies to transform the healthcare landscape and create a healthier future for all.
For more information, follow the Company on X, LinkedIn or visit .
OptimizeRx Contact
Andy D'Silva, Chief Business Officer
...
Investor Relations Contact
Douglas Farrell
LifeSci Advisors, LLC
...

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment